Terug
Dagbereik
€ 22,31
€ 22,31
52-Weeksbereik
€ 16,35
€ 25,69
Volume
252
50D / 200D Gem.
€ 21,51
/
€ 20,84
Vorige Slotkoers
€ 22,31
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 34,7 | 0,4 |
| P/B | 6,9 | 2,9 |
| ROE % | 20,7 | 3,7 |
| Net Margin % | 29,5 | 3,9 |
| Rev Growth 5Y % | -10,0 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 23,65
+6.0%
Low: € 21,30
High: € 26,00
Forward K/W
28,2
Forward WPA
€ 0,79
WPA Groei (sch.)
+0,0%
Omzet Sch.
2,3 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,13
€ 0,12 – € 0,13
|
3,3 B | 1 |
| FY2029 |
€ 1,25
€ 1,22 – € 1,28
|
3,1 B | 1 |
| FY2028 |
€ 1,07
€ 1,04 – € 1,09
|
2,8 B | 1 |
Belangrijkste Punten
Revenue declined -9,96% annually over 5 years
Earnings grew 184,46% over the past year
ROE of 20,67% indicates high profitability
Net margin of 29,46% shows strong profitability
Debt/Equity of 0,08 — conservative balance sheet
Generating 445,60M in free cash flow
Groei
Revenue Growth (5Y)
-9,96%
Revenue (1Y)-27,18%
Earnings (1Y)184,46%
FCF Growth (3Y)307,00%
Kwaliteit
Return on Equity
20,67%
ROIC-13,62%
Net Margin29,46%
Op. Margin-28,98%
Veiligheid
Debt / Equity
0,08
Current Ratio1,87
Interest Coverage-33,42
Waardering
P/E Ratio
34,73
P/B Ratio6,93
EV/EBITDAN/A
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -27,18% | Revenue Growth (3Y) | -10,23% |
| Earnings Growth (1Y) | 184,46% | Earnings Growth (3Y) | 22,76% |
| Revenue Growth (5Y) | -9,96% | Earnings Growth (5Y) | -7,90% |
| Profitability | |||
| Revenue (TTM) | 1,28B | Net Income (TTM) | 377,20M |
| ROE | 20,67% | ROA | 14,79% |
| Gross Margin | 41,41% | Operating Margin | -28,98% |
| Net Margin | 29,46% | Free Cash Flow (TTM) | 445,60M |
| ROIC | -13,62% | FCF Growth (3Y) | 307,00% |
| Safety | |||
| Debt / Equity | 0,08 | Current Ratio | 1,87 |
| Interest Coverage | -33,42 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 34,73 | P/B Ratio | 6,93 |
| P/S Ratio | 10,23 | PEG Ratio | 0,26 |
| EV/EBITDA | N/A | Dividend Yield | 0,01% |
| Market Cap | 13,10B | Enterprise Value | 12,99B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,28B | 1,76B | 1,59B | 1,64B | 1,95B |
| Net Income | 377,20M | 132,60M | 250,30M | 376,90M | 524,20M |
| EPS (Diluted) | 0,64 | 0,23 | 0,43 | 0,65 | 0,91 |
| Gross Profit | 530,20M | 1,06B | 945,90M | 1,01B | 1,22B |
| Operating Income | -371,00M | 254,40M | 334,70M | 509,10M | 723,20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,55B | 2,28B | 2,20B | 2,11B | 2,08B |
| Total Liabilities | 660,40M | 522,60M | 451,10M | 427,30M | 554,10M |
| Shareholders' Equity | 1,89B | 1,76B | 1,75B | 1,68B | 1,52B |
| Total Debt | 153,30M | 189,10M | 145,80M | 104,30M | 118,40M |
| Cash & Equivalents | 264,50M | 82,00M | 121,00M | 89,90M | 97,30M |
| Current Assets | 935,40M | 704,90M | 774,20M | 887,90M | 920,00M |
| Current Liabilities | 500,40M | 385,00M | 289,80M | 303,90M | 427,50M |